Systematic Ayurvedic Pharmacological Review of Bhrihatdhatryadi Kwath for Mutravaha Srotas Disorders: A Professional Research Paper
International Journal of Drug Delivery Technology · 04.08.2026 · 16 (72s)
DOI: 10.25258/ijddt.16.72s.20 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 04.08.2026. Verfasst von Virendra B. Pawar und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Ayurveda considers Dravya as one of the four essential pillars of treatment and places particular emphasis on rational selection of drugs according to Rasa, Guna, Virya, Vipaka, Prabhava and disease-specific action. The supplied Drug Review document presents Bhrihatdhatryadi Kwath as a classical polyherbal formulation used in relation to Mutravaha Srotas and urinary disorders. To convert the supplied drug-review material into a systematic professional research paper without adding unrelated experimental claims, and to present an integrated Ayurvedic and pharmacological appraisal of the formulation. The attached document was treated as the source dataset. Information was organized under classical background, formulation composition, botanical identity, part used, Ayurvedic pharmacodynamic attributes, Roghnata, Karma, reported chemical constituents and pharmacological activities. A narrative synthesis was then prepared with tables, graphs and a flow diagram.
Results
The formulation contains eight principal ingredients: Amlaki, Draksha, Yashtimadhu, Vidarikanda, Darbhamoola, Ikshumoola, Haritaki and Gokshur. All ingredients are linked with urinary, pitta-vata, daha, trishna, mutrakrichchra or supportive restorative actions. Most drugs possess Sheeta Virya and Madhura Vipaka, indicating a cooling, soothing and restorative orientation, while Haritaki provides Ushna, Laghu and Ruksha attributes that support Anulomana and Srotoshodhana. The review also records diuretic, antioxidant, antimicrobial, anti-inflammatory, demulcent, tonic, spasmolytic and cytoprotective activity clusters across the constituent drugs.
Conclusion
The formulation shows a coherent classical rationale for use in Mutravaha Srotasrelated complaints, particularly where urinary discomfort is associated with burning, pitta-vata involvement, debility and inflammation. The paper remains a review-based synthesis of the supplied document and does not claim new clinical efficacy data.
Zitieren
APA
Pawar, V. B., & Jagdale, S. P. (2026). Systematic Ayurvedic Pharmacological Review of Bhrihatdhatryadi Kwath for Mutravaha Srotas Disorders: A Professional Research Paper. International Journal of Drug Delivery Technology, 16(72s). https://doi.org/10.25258/ijddt.16.72s.20
Vancouver
Pawar VB, Jagdale SP. Systematic Ayurvedic Pharmacological Review of Bhrihatdhatryadi Kwath for Mutravaha Srotas Disorders: A Professional Research Paper. International Journal of Drug Delivery Technology. 2026;16(72s). doi:10.25258/ijddt.16.72s.20
BibTeX
@article{Pawar2026,
author = {Pawar, Virendra B. and Jagdale, Srushti P.},
title = {Systematic Ayurvedic Pharmacological Review of Bhrihatdhatryadi Kwath for Mutravaha Srotas Disorders: A Professional Research Paper},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {72s},
doi = {10.25258/ijddt.16.72s.20}
}
EUVIMED